The story has been updated to include comments from Exact Sciences conference call. 

NEW YORK(GenomeWeb) – Exact Sciences today reported $4.3 million in revenues for the first quarter, beating the consensus Wall Street estimate of $4.1 million. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.